Advances in vaccine platforms and scalable bioprocesses continue to reshape development timelines and supply chains. World Vaccine Congress Europe 2027 convenes industry R&D, manufacturers and solution providers in Lyon on 26–27 October to address technical and commercial choices across the vaccine value chain.
Practical information for World Vaccine Congress Europe 2027
The congress and exhibition take place at Eurexpo in Lyon. Official dates for the congress are 26 to 27 October 2027. The program spans clinical development, manufacturing and access topics and includes exhibition space and partnering tools.
Who attends and who exhibits
Organizers report around 2,000 attendees and some 150 exhibitors. The audience includes CMC and manufacturing leaders, vaccine R&D teams, and business development professionals. Exhibitors range from CDMOs and bioprocessing suppliers to formulation and cold-chain logistics companies.
Program highlights and technical themes
The agenda covers pre-clinical development through commercial manufacture. Key themes listed include bioprocessing and scale-up, pandemic-ready platforms, influenza and respiratory vaccines, cancer immunotherapy, immune profiling and regulatory strategy. Sessions also target supply and last-mile delivery challenges.
Key figures at a glance
- Approximately 2,000 attendees
- Around 150 exhibitors
- Roughly 280 speakers
- 18,000+ recorded networking connections on the event platform
These figures help size the commercial and technical reach of the congress.
Commercial outreach and partnering tactics
The event integrates 1-to-1 partnering. To approach prospects efficiently, map target companies by capability, prepare a concise value proposition focused on CMC or scale-up, and request short technical slots to evaluate fit. Share clear milestones and scale indicators so potential CDMO partners can assess capacity quickly.
Practical tips for exhibitors and delegates
- Use the event floorplan to schedule meetings with CDMOs and suppliers of bioprocess equipment.
- Prioritize technical documents that demonstrate process transferability and scale potential.
- Book partnering slots early to secure meetings with decision makers.
World Vaccine Congress Europe 2027 is a concentrated environment to audit manufacturing options and regulatory pathways for vaccine programs. If your priority is to identify partners capable of technical scale-up and regulatory support, structure meetings around CMC readiness and manufacturing timelines. Full details on registration, agenda and exhibiting are available at the official site http://www.terrapinn.com/conference/world-vaccine-congress-europe.
Imágenes



Registration and tickets on the official website: secure.terrapinn.com